To investigate potential gender differences in the role of hypertension as a risk factor for metabolic syndrome (MetS) we used a random population sample of 50-year-old men (n ¼ 595) and women (n ¼ 667; all born in 1953) who were examined in 2003 --2004. Systolic (SBP) and diastolic (DBP) blood pressure values were dichotomized at X140 mm Hg and X90 mm Hg, respectively. MetS was defined using NCEP (National Cholesterol Education Programme) and IDF (International Diabetes Federation) criteria. MetS was more prevalent in men than in women (NCEP 16% versus 10%, P ¼ 0.003; IDF 26% versus 16%, P ¼ 0.000) and systolic hypertension was more common in men than in women (high SBP 24% versus 18%, P ¼ 0.003; high DBP 29% versus 24%, P ¼ 0.074). Women with high SBP had about a seven-fold increased NCEP risk compared with normotensive women (odds ratio (OR) 6.91, confidence interval (CI) 2.90 --16.42), whereas high SBP in men was associated with about a threefold increased NCEP risk (OR 2.72,. A similar pattern was observed for the IDF criterion of MetS. All interaction terms (sex Â hypertension) were significant at Po0.01. At middle age, despite that fewer women had hypertension or MetS than men, hypertension carries a relatively greater risk for MetS in women than in men.
INTRODUCTION
Hypertension is a highly prevalent condition and a major contributor to the development of cardiovascular disease (CVD) in both genders. 1 --3 Hypertension frequently occurs in conjunction with other cardiometabolic risk factors and clustering of certain risk factors in an individual constitutes the condition now referred to as metabolic syndrome (MetS), which includes high blood pressure (BP), glucose intolerance, dyslipidaemia and abdominal obesity. 4, 5 Although there is a debate surrounding the concept of MetS, 6 --8 the syndrome and its components are recognized as strong predictors of CVD in hypertensive men and women. 2, 9 Therefore, recent clinical guidelines for the treatment of hypertension stress the importance of identification and appropriate management of multiple metabolic risk factors in hypertensive patients. 10 Although hypertension is a major predictor of CVD in both men and women, there is gender-specific variability in the outcome of cardiovascular-related events associated with high BP. 11, 12 In a comparison of the CVD risk associated with systolic BP (SBP) measurements a large cohort of men and women followed-up for 11.2 years from the general population of 11 countries demonstrated that the absolute risk of all fatal and non-fatal cardiovascular events is lower in women than in men. 11 However, the relative risk of all cardiovascular events associated with an increase in SBP is steeper in women than in men. 11 In the Framingham study hypertension is reported to account for 39% of coronary heart failure events in men and 59% in women. 12 Given the gender-specific influence of hypertension on cardiovascularrelated events demonstrated in previous studies, 11, 12 the influence of hypertension on the risk of MetS may differ between men and women. Although the epidemiology of the MetS has been described in the general population, the risk of MetS in men relative to women with hypertension has received relatively little attention. This study assessed gender differences in the role of hypertension as a risk factor for MetS in 50-year-old Swedish men and women born in 1953.
METHODS
Starting in 1963 and every 10th year thereafter, population samples of 50-year-old men living in the city of Gothenburg were examined for cardiovascular risk factors. During the fifth examination period (that is, in 2003), 50-year-old women living in Gothenburg were also included for the first time. The present study includes data from the year 2003 and the population consists of 1987 men (n ¼ 993) and women (n ¼ 994) born in 1953 who were randomly selected from the Swedish population register. The study was carried out between August 2003 and December 2004 with a questionnaire survey in conjunction with physical and clinical examinations. Altogether, 595 men (60% of those selected) and 667 women (67% of those selected) took part in the study.
Data on smoking habits, physical activity, psychological stress and having diabetes were collected by sending a postal questionnaire to the participants. Regular smoking was defined as those who smoked daily versus non-smokers. Leisure time physical activity was rated on a four point scale. Rate 1 indicated as sedentary, rate 2 as moderate activity, rate 3 as regular exercise and rate 4 as athletic training. Very few did athletic training (0.9%), and the variable physical inactivity was defined by merging rates 2 --4 versus rate 1. Psychological stress was assessed based on the single question reading 'feeling tense, irritable or filled with anxiety or having sleeping difficulties as a result of conditions at work or at home'. The alternative responses were on a six-point scale, where 0 indicated 'never experienced stress', 1 'one period of stress ever', 2 'some periods in the past 5 years', 3 'several periods in the past 5 years', 4 'permanent stress in the past year', and 5 'permanent stress over the past 5 years'. Severe stress was defined by merging points 4 and 5 versus 0 --3. Diabetes was defined as having a physician's diagnosis of diabetes.
Participants who returned the questionnaire were invited for a physical examination, which included the collection of blood samples. Full details of the procedures are reported elsewhere. 13 --16 In brief, all examinations were done in the morning after an overnight fast. Body weight was measured on a lever balance to the nearest 0.1 kg, whereas height was measured barefoot to the nearest centimeter. Waist circumference was measured at standing position at the level of the umbilicus (in cm) and hip circumference at the level of the anterior iliac crest (in cm). Body mass index (BMI ¼ weight in kg/(height in m) 2 ) and waist hip ratio (WHR) were calculated. Blood pressure measurements were done in the sitting position after a minimum of 5 min of rest by a nurse using a standard cuff and a mercury manometer (Omron 711 Automatic Blood Pressure Monitor with IntelliSense, Lake Forest, IL, USA). No correction was made for arm circumference. Blood samples were drawn from an antecubital vein and fasting serum cholesterol, plasma glucose, triglyceride, high-density lipoprotein (HDL), low-density lipoprotein (LDL) measurements were determined according to standard laboratory procedures.
Systolic hypertension was defined as SBP X140 mm Hg versus o140 mm Hg, and diastolic hypertension was defined as diastolic blood pressure (DBP) X90 mm Hg versus o90 mm Hg. MetS was defined using the National Cholesterol Education Programme (NCEP) 17 and International Diabetes Federation (IDF) 18 criteria. According to NCEP criteria, at least three of the following had to be present: fasting glucose level X6.1 mmol l À1 ; BP X130/X85 mm Hg; triglycerides X1.7 mmol l À1 ; HDL-cholesterol o1.03 mmol l À1 (men), o1.29 mmol l À1 (women); or waist circumference X102 cm (men), X88 cm (women). According to IDF criteria, waist circumference X94 cm in men and X80 cm in women plus at least two of the following had to be present: fasting glucose level X5.6 mmol l À1 or known type 2 diabetes, systolic BP X130 mm Hg and or diastolic BP X85 mm Hg or treatment for hypertension, triglycerides X1.7 mmol/l or specific treatment and HDL-cholesterol o1.03 mmol l À1 in men and o1.29 mmol l À1 in women or specific treatment.
Statistical methods
Differences in the distribution of MetS and other cardiovascular risk factors in men and women with high BP versus low BP (SBP and DBP) were examined using the Chi-square test for categorical variables and Student's t-test for continuous variables. All P-values were two-tailed and values o0.05 were considered significant. The association between hypertension and MetS was assessed by means of logistic regression, where MetS was entered as a dependent variable. Gender differences in the role of hypertension on MetS were examined by entering a two-way interaction term (sex Â hypertension) in the regression model (separately for SBP and DBP). All regression analyses were repeated after controlling for smoking, physical inactivity, and stress as possible confounders. Estimates derived from these models are expressed as odd ratios (ORs) and 95% confidence intervals (CIs). Statistical analyses were performed using SPSS, Windows version 18.0 (SPSS Inc., Chicago, IL, USA) and graphics were produced using Microsoft Office Excel 2007 and R version 2.12.1 (The R Foundation for Statistical Computing, free software distributed under GNU style copyleft).
RESULTS
In this Swedish cohort of 50-year-old men and women a significantly higher proportion of men had MetS, high SBP and higher levels of most other CVD risk factors than women of the same age (Table 1) . Only permanent stress was more common in women than in men (23% versus 17%, P ¼ 0.015). Men and women did not differ in high DBP, total cholesterol level, smoking and physical inactivity.
Comparing men and women with low SBP The prevalence of MetS was significantly higher in men than in women with low SBP (Table 2 ). In addition, men with low SBP had a higher mean BMI, WHR, LDL cholesterol, lower HDL cholesterol, higher triglycerides, higher fasting glucose and were diabetic than women with low SBP. Men and women with low SBP did not differ in average DBP, total cholesterol level, smoking and physical inactivity. More women than men with low SBP reported permanent stress.
Comparing men and women with high SBP The prevalence of MetS (both NCEP and IDF) did not differ between men and women with high SBP (Table 2 ). For instance, Metabolic syndrome in 50-year-old hypertensive men and women M Novak et al 26.6% of the men and 29.3% of the women with high SBP had MetS (NCEP; P ¼ 0.625). In addition, smoking, physical inactivity, permanent stress and diabetes, as well as average DBP, BMI, hip, total cholesterol and LDL levels were similar between men and women with high SBP. However, men with high SBP had higher triglycerides, fasting glucose, waist, WHR and lower HDL cholesterol levels.
Comparing low versus high SBP in men and women For both genders, the prevalence of MetS was more common and average levels of BMI, waist, WHR, triglycerides and fasting glucose were higher in subjects with high SBP than their low SBP counterparts ( Table 2 ). The prevalence of smoking, physical inactivity, permanent stress and level of HDL were similar between low and high SBP subjects of both genders. However, women with high SBP had higher cholesterol and LDL levels and were more often diabetic than women with low SBP; such differences were not present between men with low and those with high SBP.
The differences in the distribution of MetS and other cardiovascular risk factors according to DBP status were quite similar to those for SBP status in Table 2 , with an exception that there was no significant difference in average fasting glucose level between subjects with low and high DBP of both genders (Table  not shown) . Figure 1 presents the prevalence (%) of various components of MetS in men and women with low and high SBP and DBP according to the NCEP definition. Hypertension was the most common component of MetS in both men and women, regardless of level of SBP or DBP. The second most frequent component of MetS in women was high waist circumference, whereas in men it was a high level of triglycerides. A significantly higher proportion of women with high BP exhibited a particularly altered level of waist circumference compared with normotensive women (P ¼ 0.000), whereas the difference in men was not as steep (P ¼ 0.024 for high SBP) or non-significant (P ¼ 0.411 for high DBP). For example, about 39% systolic and 40% diastolic hypertensive women had high waist circumference, whereas the corresponding figures in hypertensive men were 20 and 25%. Women with hypertension also exhibited significantly higher levels of triglyceride than their normotensive counterparts (P ¼ 0.000). The difference was not as steep between hypertensive and normotensive men (P ¼ 0.006 for high SBP, P ¼ 0.033 for high DBP).
Significant gender Â hypertension interactions, with a more adverse influence of hypertension in women, were noted for MetS for both NCEP and IDF definitions (Figure 2) . The unadjusted OR for MetS (NCEP) in women with high SBP was 6.41 (95% CI: 3.71 --11.06); in men the OR was 2.57 (95% CI: 1.61 --4.10; P ¼ 0.012 for interaction). For high DBP, the OR for MetS (NCEP) in women was 5.89 (95% CI: 3.46 --10.01) and the OR for men was 1.95 (95% CI: 1.23 --3.08; P ¼ 0.002 for interaction). The OR for MetS---defined according to IDF---in women with high SBP was 4.85 (95% CI: 3.05 --7.72) and in men 1.78 (95% CI: 1.19 --2.68; P ¼ 0.001 for interaction). For high DBP, the OR for MetS (IDF) in women was Metabolic syndrome in 50-year-old hypertensive men and women M Novak et al 4.78 (95% CI: 3.07 --7.45) and in men 2.20 (95% CI: 1.49 --3.25; P ¼ 0.009 for interaction). These gender-specific associations were not attenuated when adjusting for smoking, physical inactivity and severe stress (Figure 2 ).
DISCUSSION
In our study of 50-year-old men and women, more men were hypertensive and more men had a higher prevalence of MetS than women. There was a significant interaction between gender and hypertension as indicated in our results that hypertensive women had significantly higher levels of several components of the MetS compared with their normotensive counterparts, whereas the differences in men were less pronounced. Our results revealed that women who had high BP had about a four-to seven-fold increased MetS risk compared with normotensive women. In contrast, high BP in men was associated with about a two-to three-fold increased MetS risk compared with normotensive men. There was no attenuation of these associations after adjusting for smoking, physical inactivity and severe stress. We are not aware of other studies illustrating this gender Â hypertension interaction and risk of MetS in middle-aged population.
The mechanism leading to a greater increase of MetS risk in middle-aged hypertensive women found in our study are not clearly understood. One potential explanation could be that hypertensive women in our study had other additional cardiovascular risk factors (that is, other than MetS) than normotensive women, whereas hypertensive men did not present with additional cardiovascular risk factors than normotensive men. The additional cardiovascular risk factors found in hypertensive women in our study were diabetes, higher total cholesterol and a higher LDL level (Table 2) . It is well recognized that MetS strongly predicts diabetes 19 and that diabetes is a stronger coronary heart disease risk factor for women than for men. 20 The presence of more additional risk factors (for example, diabetes, BMI430, hyperlipidaemia and smoking) in hypertensive women relative to hypertensive men has been previously reported in an elderly population. 21 The gender-specific risk of MetS found in our study may also be partly related to gender variations in certain components of the Figure 2 . Adjusted odds ratios and 95% confidence intervals for MetS among men and women with high BP. Adjusted for smoking, physical inactivity and severe stress.
MetS in hypertensive patients. We found that a significantly higher proportion of women with hypertension exhibited an altered level of waist circumstance. For example, according to NCEP criteria, about 40% of the hypertensive women had high waist circumference (the percent in men was 20 --25%). For most individuals, the development of MetS starts with abdominal obesity without any other risks factors. With time, however, multiple risk factors are likely to appear, initially with only borderline elevations but then with progressive worsening. 22 The Dallas-Heart study data have shown that for a given level of waist circumference, women exhibit more adverse metabolic risk factors than men. 23 It has also been shown that women with increased waist circumference exhibit significantly altered levels of several adverse cardiometabolic risks factors. 9 Even so, it must be recognized that the genderspecific definitions might be considered arbitrary, but that aside, other components of the MetS were also more common in hypertensive women than in normotensive women. We found that a significantly higher proportion of women with hypertension had an altered level of triglycerides, that is, hypertensive women had a higher level of triglycerides than normotensive women. In contrast, differences in hypertensive and normotensive men were relatively less pronounced. One study in an elderly Greek population demonstrated a higher prevalence of hyperlipidaemia in hypertensive women compared with normotensive women, whereas the prevalence of hyperlipidaemia did not differ between hypertensive and normotensive men. 21 Additional factors associated with the development of hypertension in women several mechanisms have been proposed such as hemodynamic, vascular, metabolic and neurohormonal mechanisms. 24 An important limitation in this study was that we neither had information on the menopausal state of women nor on hormone replacement therapy. It is well documented that premenopausal women are relatively safer from CVD as compared with men of the same age. 25 However, women's risk of CVD increases after menopause. 20 For instance, premenopausal women have a lower tendency to develop hypertension than do age-matched men. However, the increase in the hypertension rate with advancing age is steeper in women than in men. 26 Furthermore, in postmenopausal women hypertension is reported to carry a relatively greater risk of CVD in women compared with men of the same age. 12 Because of a lack of information on the menopausal state of women in our study, we could not assess its influence on the risk of MetS in hypertensive women. However, our study concerns only 50-year-old cohorts and the median age of natural menopause in Sweden is 51.5 years. 27 Therefore, we believe that our study generally describes the gender differences in the role of hypertension as a risk factor for MetS in the perimenopausal and premenopausal state. Furthermore, treatment of hypertension may influence the gender specific association found in the present study. However, information of BP treatment on this study cohort was limited to only if they were currently taking any BP medication or not and no questions were asked on type or number of medications. We did however repeat our analysis by controlling for the available information on whether they were taking any BP medication or not and found our results and conclusions unchanged.
In conclusion, this study showed that in middle age, despite a more favorable cardiovascular profile in women, hypertension carries a relatively greater risk for MetS in women than it does in men. Although in recent years gender differences in CVD risk have increasingly been recognized in the medical profession, usually clinical management of MetS is not tailored in a gender-specific manner. 25 Further research is needed to ascertain a better understanding of the pathophysiology underlying gender differences in MetS in order to identify gender-specific criteria for prevention, diagnosis and treatment of MetS in hypertensive patients. Given that the risk of metabolic aberrations is greater in hypertensive women than in hypertensive men at age 50, as was observed in our study, suggests that lifestyle interventions, known to be effective in reducing the clustering of risk in the MetS and potentially also treatment to reach recommended BP levels, should be more aggressive for women. Furthermore, the extent of the MetS risk should encourage middle-aged non-hypertensive women to take measures in maintaining optimal blood pressure level for preventing the development of hypertension, as well as in maintaining abdominal weight gain (waist circumference).
What is known about this topic
There is gender-specific variability in the outcome of cardiovascularrelated events associated with high blood pressure where the risk is reported to be higher in women than in men. 11, 12 Given the gender-specific influence of hypertension on cardiovascular-related events demonstrated in previous studies, 11, 12 the influence of hypertension on the risk of metabolic syndrome (MetS) may differ between men and women. The epidemiology of the metabolic syndrome has been described in the general population, however, the risk of MetS in men relative to women with hypertension has received relatively little attention.
What this study adds At age 50, more men were hypertensive and more men had a higher prevalence of MetS than women.
There was a significant interaction between gender and hypertension as indicated in our results that women who had high BP had about a four-to seven-fold increased MetS risk compared with normotensive women. In contrast, high BP in men was associated with about a two-to threefold increased MetS risk compared with normotensive men. Hypertensive women in our study had other additional cardiovascular risk factors (i.e., diabetes, higher total cholesterol and higher LDL level) than normotensive women, whereas hypertensive men did not present with additional cardiovascular risk factors than normotensive men. A significantly higher proportion of women with hypertension exhibited an altered level of waist circumstance and had a higher level of triglycerides than normotensive women. In contrast, differences in hypertensive and normotensive men were relatively less pronounced. At middle age, despite that fewer women had hypertension compared with men, hypertension carries a relatively greater risk for MetS in women than it does in men.
We are not aware of other studies illustrating this gender Â hypertension interaction and risk of MetS in middle-aged population.
